Opus Genetics's total assets for Q4 2025 were $50.24M, an increase of 39.09% from the previous quarter. IRD total liabilities were $34.90M for the fiscal quarter, a 15.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.